CDRE

Cadre (D/B/A The Safariland Group) is a profitable, durable niche leader in body armor, duty gear and EOD/nuclear safety equipment with recurring modernization-and-replacement demand from law enforcement, military and federal agencies. The five-year revenue arc is steady and upward ($427M→$458M→$483M→$568M→$610M), FY2025 revenue grew 7.5% to $610M, and net income rose 22.2% to $44.1M. Gross margin is a healthy 42.5% and expanded (gross profit +11.2%), operating cash flow doubled to $63.7M, current assets cover current liabilities 3.5x, and a record orders backlog of $189.8M (up 47% from $128.8M) is a genuine forward-sales tailwind. This is a real business, not a story stock.

The blemish is below the gross line. Despite +7.5% sales and +11.2% gross profit, operating income was essentially flat (+0.9%, margin slipping to 11.0%) — management attributes the SG&A bloat to acquisition-related costs, higher interest and stock comp. Growth is increasingly bought rather than organic: Zircaloy ($98.9M, April 2025) and the much larger TYR Tactical ($174.0M, January 2026) drove much of the top-line gain alongside duty-gear strength, while EOD and existing nuclear-safety products declined. Funding that M&A pushed long-term debt up 37.4% to $291M ($309.1M total outstanding per the 10-K), lifting liabilities/equity to 1.42x. The net-income growth outrunning operating income is therefore lower-quality than it looks.